Medication overuse headache checker
Medication overuse headache (rebound headache) happens when frequent use of the medicines that treat headache starts to make headaches more frequent. It’s common, easy to miss, and very treatable once you spot it. The limits are set in days a month, not pills, and they differ by medicine. Enter your days below to see where you stand.
Private by design. Your answers stay on your device.

Loading the calculator. If it doesn’t appear, check that JavaScript is turned on. The guide below lets you work it out by hand.
Medication overuse headache limits by medicine
The International Classification of Headache Disorders (ICHD-3) sets these limits, counted as days a month for more than 3 months:
| Medicine | Overuse at |
|---|---|
| Triptans (sumatriptan, rizatriptan and others) | 10 or more days |
| Lasmiditan (Reyvow), going by its label | 10 or more days |
| Ergots (ergotamine, DHE) | 10 or more days |
| Opioids (codeine, tramadol and others) | 10 or more days |
| Combination painkillers (with caffeine, codeine or butalbital) | 10 or more days |
| Several kinds mixed, none over its own limit | 10 or more days in total |
| Acetaminophen (paracetamol) or aspirin alone | 15 or more days |
| NSAIDs (ibuprofen, naproxen and others) | 15 or more days |
For a diagnosis of medication overuse headache you also need headache on 15 or more days a month in someone who already had a headache disorder like migraine.
What about gepants?
Gepants (ubrogepant, rimegepant and zavegepant) came out after ICHD-3 was written, so they aren’t on its list. Studies so far haven’t shown them causing medication overuse headache, but long-term data are still limited. Rimegepant and atogepant are even used as preventives. The checker shows your gepant days but leaves them out of the count.
Lasmiditan (Reyvow) is different. It isn’t a gepant, and its label carries the same overuse warning as triptans and ergots: 10 or more days a month. The checker has its own lasmiditan row and counts it against that 10-day limit.
How medication overuse headache is treated
Treatment usually means two things: starting a preventive and, often, cutting back the overused medicine. In the MOTS trial, everyone started a preventive, and people who weren’t asked to cut back their acute medicine did about as well as those who were. That doesn’t apply to opioids or butalbital, and in another trial (Carlsen et al., 2020) cutting back plus a preventive did best on some measures, so talk through both routes with your doctor.
The 2026 AAN and American Headache Society guideline says a preventive should be offered to anyone with medication overuse, and suggests ones with evidence in this group first: a CGRP antibody, atogepant, Botox (onabotulinumtoxinA) or topiramate.
Opioids and butalbital aren’t recommended for migraine. The American Academy of Neurology’s Choosing Wisely advice is to use them only as a last resort, because better options exist and frequent use makes headaches worse. If you take them, don’t stop suddenly on your own. That can cause withdrawal, and with butalbital it can cause seizures, so always make a plan with your doctor first. For the full picture, read our clinical guide to medication overuse headache.
Frequently asked questions
How many days a week can I take ibuprofen for headache?
For ibuprofen and other NSAIDs, the ICHD-3 limit is 15 days a month. To stay under it, keep to about 3 days a week at most, and many headache specialists suggest 2. If you need it that often, it’s worth talking with your doctor about prevention.
How many triptans a month is too many?
The limit is counted in days, not doses. Taking a triptan on 10 or more days a month for more than 3 months counts as overuse.
What does a rebound headache feel like?
There isn’t one tell-tale feeling. The clue is the pattern: headaches becoming more frequent, often daily or near-daily, at the same time as you’re taking acute medicine more often. Many people notice a headache on waking that eases with their usual pill.
How long does medication overuse headache last after stopping?
Headaches often get worse for a few days to a couple of weeks after cutting back, then improve. Many people end up with fewer headache days than before over the following months.
Do gepants cause rebound headaches?
So far, there’s no sign that they do. Gepants came out after ICHD-3 was written, so they aren’t on its list. Studies so far haven’t shown them causing medication overuse headache, but long-term data are still limited.
More free migraine tools
- MIDAS calculatorHow many days migraine has cost you over 3 months, and your disability grade.
- HIT-6 calculatorHow much headaches get in the way of daily life, from 6 quick questions.
- Do I have migraine?The 3-question ID Migraine screener that many doctors use.
- Chronic migraine calculatorEpisodic or chronic, and whether guidelines say prevention is due.
- Medication overuse checkerYour medicine days against the ICHD-3 limits for rebound headache.
- Is my preventive working?Your percent drop in migraine days, and whether it has had a fair trial.
- Caffeine calculatorYour daily caffeine total and where it lands for migraine.
- Visit summary builderA one-page summary for your next appointment, built around what headache specialists ask. You can talk your answers in.
References
- Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition. Section 8.2, Medication-overuse headache. Cephalalgia. 2018;38(1):1-211. PubMed
- Schwedt TJ, Hentz JG, Sahai-Srivastava S, et al. Patient-centered treatment of chronic migraine with medication overuse: a prospective, randomized, pragmatic clinical trial. Neurology. 2022;98(14):e1409-e1421. (MOTS) PubMed
- Carlsen LN, Munksgaard SB, Nielsen M, et al. Comparison of 3 treatment strategies for medication overuse headache: a randomized clinical trial. JAMA Neurol. 2020;77(9):1069-1078. doi:10.1001/jamaneurol.2020.1179
- Potrebic S, Tanveer S, Becker WJ, et al. Pharmacologic treatment for migraine prevention in adults: practice guideline recommendations. Report of the AAN Guidelines Subcommittee and the American Headache Society. Neurology. 2026;107(7):e214881. doi:10.1212/WNL.0000000000214881
- Langer-Gould AM, Anderson WE, Armstrong MJ, et al. The American Academy of Neurology’s top five Choosing Wisely recommendations. Neurology. 2013;81(11):1004-1011. PubMed
- Reyvow (lasmiditan) prescribing information. Section 5.4, Medication overuse headache. Eli Lilly and Company. Drugs.com
This tool is for education and to help you talk with your doctor. It doesn’t diagnose anything and isn’t medical advice. Your answers stay in your browser and are never sent to Cerebral Torque.
This tool is for education and to help you talk with your clinician. It is not a diagnosis.
Try another


